Patten Group’s Idexx Laboratories IDXX Stock Holding History

Patten Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.85M	Sell	5,074 -6	-0.1%	-$3.85K	0.5%	57
2025 Q4	$3.44M	Sell	5,080 -215	-4%	-$146K	0.64%	37
2025 Q3	$3.38M	Sell	5,295 -19	-0.4%	-$11.5K	0.66%	37
2025 Q2	$2.85M	Buy	5,314 +15	+0.3%	+$7.17K	0.6%	41
2025 Q1	$2.23M	Sell	5,299 -505	-9%	-$219K	0.51%	51
2024 Q4	$2.4M	Sell	5,804 -804	-12%	-$353K	0.53%	51
2024 Q3	$3.34M	Sell	6,608 -119	-2%	-$57.8K	0.74%	29
2024 Q2	$3.28M	Hold	6,727	–	–	0.77%	28
2024 Q1	$3.63M	Sell	6,727 -58	-0.9%	-$31.7K	0.89%	23
2023 Q4	$3.77M	Buy	6,785 +37	+0.5%	+$17.4K	1.02%	18
2023 Q3	$2.95M	Sell	6,748 -65	-1%	-$32.4K	0.88%	24
2023 Q2	$3.42M	Sell	6,813 -109	-2%	-$52.2K	0.51%	19
2023 Q1	$3.46M	Sell	6,922 -230	-3%	-$110K	1.04%	17
2022 Q4	$2.92M	Buy	7,152 +55	+0.8%	+$21.3K	0.92%	26
2022 Q3	$2.37M	Buy	7,097 +62	+0.9%	+$22.8K	0.81%	26
2022 Q2	$2.69M	Sell	7,035 -26	-0.4%	-$10.6K	0.86%	23
2022 Q1	$3.86M	Sell	7,061 -60	-0.8%	-$31.6K	1.08%	15
2021 Q4	$4.69M	Sell	7,121 -470	-6%	-$295K	1.24%	14
2021 Q3	$4.72M	Sell	7,591 -44	-0.6%	-$29.6K	1.39%	12
2021 Q2	$4.82M	Sell	7,635 -199	-3%	-$110K	1.42%	12
2021 Q1	$3.83M	Sell	7,834 -91	-1%	-$45.6K	1.23%	13
2020 Q4	$3.96M	Sell	7,925 -198	-2%	-$88.6K	1.07%	17
2020 Q3	$3.19M	Sell	8,123 -20	-0.2%	-$7.39K	1.25%	13
2020 Q2	$2.69M	Sell	8,143 -30	-0.4%	-$8.69K	1.16%	16
2020 Q1	$1.98M	Sell	8,173 -290	-3%	-$75.7K	1.02%	22
2019 Q4	$2.21M	Sell	8,463 -400	-5%	-$105K	0.82%	33
2019 Q3	$2.41M	Sell	8,863 -300	-3%	-$83.5K	0.98%	26
2019 Q2	$2.52M	Sell	9,163 -80	-0.9%	-$19.7K	1.03%	26
2019 Q1	$2.07M	Buy	9,243 +950	+11%	+$196K	0.89%	35
2018 Q4	$1.54M	Buy	8,293 +3,358	+68%	+$688K	0.73%	36
2018 Q3	$1.23M	Sell	4,935 -40	-0.8%	-$9.71K	0.47%	64
2018 Q2	$1.08M	Sell	4,975 -50	-1%	-$10.3K	0.43%	70
2018 Q1	$962K	Hold	5,025	–	–	0.39%	73
2017 Q4	$786K	Hold	5,025	–	–	0.31%	90
2017 Q3	$781K	Hold	5,025	–	–	0.32%	90
2017 Q2	$767K	Sell	5,025 -75	-1%	-$12.2K	0.31%	88
2017 Q1	$793K	Hold	5,100	–	–	0.34%	79
2016 Q4	$620K	Hold	5,100	–	–	0.28%	91
2016 Q3	$565K	Hold	5,100	–	–	0.27%	88
2016 Q2	$474K	Sell	5,100 -1,500	-23%	-$129K	0.22%	106
2016 Q1	$517K	Hold	6,600	–	–	0.25%	96
2015 Q4	$481K	Hold	6,600	–	–	0.23%	102
2015 Q3	$490K	Hold	6,600	–	–	0.25%	98
2015 Q2	$423K	Hold	6,600	–	–	0.2%	108
2015 Q1	$509K	Hold	6,600	–	–	0.26%	101
2014 Q4	$489K	Buy	+6,600	New	+$463K	0.24%	104

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Patten Group's IDXX Position: Q1 2026 in Review

Patten Group reduced its Idexx Laboratories (IDXX) stake by 0.12% in Q1 2026, selling an estimated $3.85K and leaving 5,074 shares worth $2.85M. The position accounts for 0.5% of the portfolio, ranked #57.

Patten Group first reported a position in IDXX in Q4 2014 and has held it in 46 quarters since. The position peaked at $4.82M in Q2 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Patten Group held 5,074 shares of Idexx Laboratories worth $2.85M as of Q1 2026.
Patten Group sold 6 Idexx Laboratories shares in Q1 2026, an estimated $3.85K.
Idexx Laboratories made up 0.5% of Patten Group's portfolio in Q1 2026, its #57 holding.
Patten Group first reported a position in Idexx Laboratories in Q4 2014 and has held it in 46 quarters since.
Patten Group's Idexx Laboratories position peaked at $4.82M in Q2 2021.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Patten Group's 13F filing for Q1 2026, filed 24 Apr 2026.